Compare, Analyse Dr. Reddys with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs MYLAN (US) - Comparison Results

DR. REDDYS LAB     Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the pharmaceutical value chain - basic research, finished dosages, generics, bulk actives, and biotechnology. The company's business is mainly organized into Global g... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DR. REDDYS LAB   MYLAN
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-19
MYLAN
Dec-18
DR. REDDYS LAB/
MYLAN
5-Yr Chart
Click to enlarge
High Rs2,8753,557-   
Low Rs1,8881,958-   
Sales per share (Unadj.) Rs930.21,636.8-  
Earnings per share (Unadj.) Rs117.444.4-  
Cash flow per share (Unadj.) Rs185.8350.9-  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs844.41,770.7-  
Shares outstanding (eoy) m166.07514.50-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.61.7 152.0%   
Avg P/E ratio x20.362.0 32.7%  
P/CF ratio (eoy) x12.87.9 163.2%  
Price / Book Value ratio x2.81.6 181.1%  
Dividend payout %17.00-   
Avg Mkt Cap Rs m395,4961,418,753 27.9%   
No. of employees `00022.035.0 62.8%   
Total wages/salary Rs m33,5620-   
Avg. sales/employee Rs Th7,032.824,060.9 29.2%   
Avg. wages/employee Rs Th1,527.90-   
Avg. net profit/employee Rs Th887.7653.4 135.9%   
INCOME DATA
Net Sales Rs m154,482842,132 18.3%  
Other income Rs m3,3750-   
Total revenues Rs m157,857842,132 18.7%   
Gross profit Rs m31,782217,913 14.6%  
Depreciation Rs m11,348157,680 7.2%   
Interest Rs m88940,504 2.2%   
Profit before tax Rs m22,92019,729 116.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m4380-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,858-3,139 -122.9%   
Profit after tax Rs m19,50022,867 85.3%  
Gross profit margin %20.625.9 79.5%  
Effective tax rate %16.8-15.9 -105.8%   
Net profit margin %12.62.7 464.9%  
BALANCE SHEET DATA
Current assets Rs m111,101470,246 23.6%   
Current liabilities Rs m58,973342,861 17.2%   
Net working cap to sales %33.715.1 223.1%  
Current ratio x1.91.4 137.4%  
Inventory Days Days7984 94.9%  
Debtors Days Days9493 100.9%  
Net fixed assets Rs m101,245163,360 62.0%   
Share capital Rs m830448 185.1%   
"Free" reserves Rs m139,4060-   
Net worth Rs m140,236911,033 15.4%   
Long term debt Rs m22,000983,297 2.2%   
Total assets Rs m224,6562,443,746 9.2%  
Interest coverage x26.81.5 1,801.0%   
Debt to equity ratio x0.21.1 14.5%  
Sales to assets ratio x0.70.3 199.5%   
Return on assets %9.12.6 350.0%  
Return on equity %13.92.5 554.0%  
Return on capital %14.93.2 470.0%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m69,5690-   
CASH FLOW
From Operations Rs m28,704174,995 16.4%  
From Investments Rs m-7,727-90,453 8.5%  
From Financial Activity Rs m-21,326-81,523 26.2%  
Net Cashflow Rs m-3141,450 -21.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 74.73 Rs / USD

Compare DR. REDDYS LAB With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare DR. REDDYS LAB With: JUBILANT LIFE SCIENCES  PROCTER & GAMBLE HEALTH  BIOCON   SANOFI INDIA  ORCHID PHARMA LTD  



Today's Market

Sensex Trades in Green; Bajaj Auto & Bharti Airtel Top Gainers(12:30 pm)

Share markets in India are trading on a positive note in today's volatile trade. Benchmark indices edged higher as positive developments in a coronavirus vaccine trial improved global risk sentiment.

Related Views On News

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (1QFY19); Net Profit Up 614.9% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 614.9% YoY). Sales on the other hand came in at Rs 37 bn (up 12.1% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

More Views on News

Most Popular

Be Prepared to Profit from the Coming Crash in Oil Prices (Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How... (Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

The Triple Digit Return Opportunity in this Market

Jun 24, 2020

Rahul Shah on stocks with potentially triple digit returns.

This Ratio Says Smallcaps Are Your Best Bet to Ride the Post Covid Market Rebound (Profit Hunter)

Jun 23, 2020

Here's why I believe that post Covid rebound in smallcaps will be much sharper than largecaps.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2020
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

DR. REDDYS LAB SHARE PRICE


Jul 3, 2020 02:53 PM

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. REDDYS LAB

DR. REDDYS LAB 8-QTR ANALYSIS

COMPARE DR. REDDYS LAB WITH

FEATURED VIDEOS

MARKET STATS